gimli

PARKHOSPS stock AI analysis

PARKHOSPS Stock AI Analysis: Price, PE, 50DMA, Shareholding and Peers

PARK MEDI WORLD LIMITED is a small-cap stock in Healthcare. This Gimli page shows the latest available PARKHOSPS price, returns, 50DMA/200DMA trend, PE, ROE, ROCE, financials, shareholding pattern, and industry peers for Indian stock screening research.

Analyze with AI Open interactive PARKHOSPS stock page

Price

₹279.00

1W return

-3.94%

1M return

+0.50%

3M return

+25.79%

6M return

+81.26%

1Y return

n/a

Market cap

₹12,050.87 cr

46.69

5.73

ROE

+15.98%

ROCE

+19.34%

RSI

48.31

Turnover

₹40.41 cr

Why it can matter in screens

Momentum: PARKHOSPS is above 50DMA, below 200DMA; RSI is 48.31.
Returns: 1D +1.84%, 1W -3.94%, 1M +0.50%, 3M +25.79%, 1Y n/a.
Trend levels: 52W high ₹299.30, 52W low ₹143.92, off high -6.78%.
Liquidity: latest turnover is ₹40.41 cr; volume vs 20D is +1.33%.
Valuation/profitability: PE 46.69, PB 5.73, ROE +15.98%, ROCE +19.34%.
Growth: 3Y sales CAGR +10.27%, 3Y profit CAGR +5.52%.

Quick Answers

What is the latest PARKHOSPS stock price?

The latest stored price for PARKHOSPS is Rs 279.00 as of 2026-07-20.

Is PARKHOSPS above its 50DMA and 200DMA?

PARKHOSPS is above 50DMA, below 200DMA. The latest 50DMA is 275.86 and the latest 200DMA is n/a.

What are PARKHOSPS PE, ROE and ROCE?

PARKHOSPS has PE 46.69, ROE +15.98%, and ROCE +19.34% in Gimli's latest available snapshot.

How has PARKHOSPS performed recently?

PARKHOSPS has returned +0.50% over 1 month, +25.79% over 3 months, and n/a over 12 months in the latest stored data.

Is this stock page investment advice?

No. This page is a data snapshot for screening and research. It is not buy, sell, legal, tax, or investment advice.

Financials and Ownership

Quarterly income statement

Period	Revenue	EBITDA	PAT	EPS
2026-03-31	460.41 cr	134.87 cr	70.86 cr	1.64
2025-12-31	409.97 cr	108.51 cr	50.78 cr	1.35
2025-09-30	418.23 cr	120.77 cr	78.53 cr	2.04
2025-03-31	353.92 cr	97.00 cr	44.84 cr	1.04
2024-12-31	348.13 cr	97.56 cr	45.59 cr	1.06

Annual income statement

Year	Revenue	EBITDA	PAT	EPS
2026-03-31	1,679.36 cr	475.93 cr	258.12 cr	6.87
2025-03-31	1,393.57 cr	403.40 cr	201.64 cr	4.67
2024-03-31	1,229.06 cr	338.27 cr	153.49 cr	3.55
2023-03-31	1,252.38 cr	404.74 cr	219.67 cr	5.09
2022-03-31	124.79 cr	35.49 cr	8.35 cr	0.53

Balance sheet

Period	Assets	Cash	Debt	Equity
2026-03-31	2,813.15 cr	236.85 cr	364.19 cr	2,104.30 cr
2025-03-31	2,133.70 cr	103.00 cr	682.07 cr	1,126.28 cr
2024-03-31	1,912.10 cr	76.63 cr	686.71 cr	935.51 cr
2023-03-31	1,592.82 cr	100.05 cr	575.68 cr	729.97 cr

Cash flow

Period	OCF	FCF	Cash change
2026-03-31	329.09 cr	209.41 cr	n/a
2025-03-31	215.38 cr	70.27 cr	n/a
2024-03-31	361.44 cr	289.98 cr	n/a
2023-03-31	195.03 cr	96.60 cr	n/a

Shareholding Trend

Period	Promoter	FII/FPI	DII	MF	Retail	Pledge
2026-06-30	+82.89%	+0.82%	+8.95%	+5.66%	+7.33%	+0.00%
2026-03-31	+82.89%	+0.86%	+9.25%	+5.62%	+6.99%	+0.00%
2025-12-31	+82.89%	+1.28%	+8.78%	+5.17%	+7.05%	+0.00%
2025-12-16	+82.89%	+1.97%	+6.66%	+2.73%	+8.48%	+0.00%

Industry Peers

Symbol	Name	Mcap	PE	ROE	1Y
SUNPHARMA	SUN PHARMACEUTICAL IND L	469,405.90 cr	40.823336	+14.71%	+15.52%
DIVISLAB	DIVI S LABORATORIES LTD	194,269.92 cr	75.650281	+16.19%	+8.71%
TORNTPHARM	TORRENT PHARMACEUTICALS L	169,405.46 cr	78.319677	+17.18%	+42.14%
APOLLOHOSP	APOLLO HOSPITALS ENTER. L	128,040.28 cr	65.380043	+21.03%	+21.93%
CIPLA	CIPLA LTD	116,452.52 cr	30.005339	+11.79%	-2.75%
ZYDUSLIFE	ZYDUS LIFESCIENCES LTD	115,616.29 cr	23.056854	+17.93%	+17.85%
LUPIN	LUPIN LIMITED	113,320.96 cr	21.221472	+26.83%	+28.27%
MAXHEALTH	MAX HEALTHCARE INS LTD	107,290.40 cr	74.382732	+14.33%	-9.32%

Try these prompts

Analyze PARK MEDI WORLD with valuation, momentum and industry peers
Compare PARKHOSPS with other Healthcare stocks
Show small-cap stocks in Healthcare above 50DMA with positive 1M return
Find Healthcare stocks with improving momentum and reasonable valuation

Related screen ideas

Data snapshot: 2026-07-20. Not investment advice.